The Propaganda for Reform in Proprietary Medicines, Vol. 1 of 2Council on Pharmacy and Chemistry (American Medical Association)
Science
The Propaganda for Reform in Proprietary Medicines, Vol. 1 of 2
Council on Pharmacy and Chemistry (American Medical Association)
Patent medicines
“Derangements of the stomach and liver.”
“Affections of the kidneys.”
“Bilious attacks.”
“‘Summer complaints,’ colic and alcoholic excesses.”
“Headache, dizziness, heartburn and seasickness.”
“Acute indigestion.”
“Gastric, hepatic and renal disorders.”
“Especially beneficial in rheumatism and gout.”
From these quotations it is evident that Sal Hepatica is in conflict
with:
_Rule 1_, in that its composition is not disclosed, although statements
are made which are likely to give a false impression as to what it is;
_Rule 4_, in that the statements on the label and in the circular
around the bottle advertise it to the public and thus make the
physician who recommends it an advance agent for the nostrum;
_Rule 6_, in that exaggerated and unwarranted claims are made for its
therapeutic qualities, and,
_Rule 8_, in that its name fails to indicate its chief constituents,
but does suggest its use in liver disorders.
The absurd claims made for this preparation are such as to put it in
the “patent medicine” class. Even the most credulous members of the
medical profession certainly can take no stock in the claim that a
preparation can be an “eliminant” of uric acid, a hepatic stimulant, a
remedy for gout, rheumatism, liver disease, indigestion, etc. Why then
should such a preparation be tolerated?
In its conflict with Rule 4 Sal Hepatica belongs to that class of
nostrums which have been so successfully exploited by manufacturers
through the unwitting efforts of thoughtless and careless physicians.
The Bristol-Myers Company has been most liberal in distributing free
samples, evidently with the assurance that physicians would do the
rest. Thus, at the present time, the profession is being supplied with
a package containing one regular 25-cent bottle and five single-dose
vials bearing the name Sal Hepatica. If only a small percentage of the
physicians who receive these samples distribute them, the increase in
Sal Hepatica consumers may be imagined. How successful this scheme of
the Bristol-Myers Company has been is only too evident. Sal Hepatica is
one of the best-selling laxatives in department stores and drug stores
to-day.
While the evils of indiscriminate purgation are now generally
recognized, the referee wishes to quote and to indorse the pertinent
comments on this subject by The Journal:[79]
[79] The Journal A. M. A., March 26, 1910, p. 1071.
Public-domain text, read in full here on John Shaqi.
Reviews
Reviews
No reviews yet
Be the first to share your thoughts on this work.
Elsewhere in the archive
Join the Discussion
Join the discussion
Sign in to leave a comment or review.
Sign InorCreate an account